Table 2.
FEV1 changes from baseline to 4 months visit in male and female subjects in the special intervention + Atrovent (SIA) group.a
| Women (n = 683) | Men (n = 1061) | p-Value | |
|---|---|---|---|
| Change in FEV1 (litres) | 0.13 ± 0.15 | 0.08 ± 0.22 | < 0.001 |
| Change in FEV1 (% change from baseline) | 6.00 ± 7.51 | 2.94 ± 7.53 | < 0.001 |
| Change in FEV1 (change in % predicted FEV1) | 4.85 ± 5.66 | 2.34 ± 5.50 | < 0.001 |
| Individuals who experienced a 140 ml or greater increase in baseline FEV1 | 301 (44.07%) | 397 (37.42%) | < 0.01 |
a
All values are post-bronchodilator.